Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr
Format:	Artykuł
Język:	English
Wydane:	Frontiers Media S.A. 2022-09-01
Seria:	Frontiers in Aging Neuroscience
Hasła przedmiotowe:	Alzheimer’s disease nicotinamide riboside gut microbiome APP/PS1 transgenic mice neuroinflammation aging
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

Podobne zapisy

Urolithin A and nicotinamide riboside differentially regulate innate immune defenses and metabolism in human microglial cells
od: Helena Borland Madsen, i wsp.
Wydane: (2024-11-01)

Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner
od: Alejandro Marmolejo-Garza, i wsp.
Wydane: (2024-10-01)

Roles of Nicotinamide Adenine Dinucleotide (NAD+) in Biological Systems
od: Palmiro Poltronieri, i wsp.
Wydane: (2018-01-01)

Nicotinamide riboside kinase 1 protects against diet and age-induced pancreatic β-cell failure
od: Angelique Cercillieux, i wsp.
Wydane: (2022-12-01)

Nicotinamide adenine dinucleotide is transported into mammalian mitochondria
od: Antonio Davila, i wsp.
Wydane: (2018-06-01)

Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
od: Rachel S. Fletcher, i wsp.
Wydane: (2017-08-01)

Comparison of protective effects of nicotinamide mononucleotide and nicotinamide riboside on DNA damage induced by cisplatin in HeLa cells
od: Shuting Qiu, i wsp.
Wydane: (2024-03-01)

Syntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives
od: Mikhail V. Makarov, i wsp.
Wydane: (2019-02-01)

How to mitigate neurological and cardiac decompensation in Leigh syndrome: Can nicotinamide riboside be an answer?
od: Alessandro Prigione, i wsp.
Wydane: (2022-09-01)

The effects of in ovo nicotinamide riboside dose on broiler myogenesis
od: Xiaoxing Xu, i wsp.
Wydane: (2021-03-01)

Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice
od: Xue Han, i wsp.
Wydane: (2019-08-01)

Rev1 deficiency induces a metabolic shift in MEFs that can be manipulated by the NAD+ precursor nicotinamide riboside
od: Sharath Anugula, i wsp.
Wydane: (2023-06-01)

The role of nicotinamide adenine dinucleotide salvage enzymes in cardioprotection
od: Fazle Kibria, i wsp.
Wydane: (2024-07-01)

Semisynthetic biosensors for mapping cellular concentrations of nicotinamide adenine dinucleotides
od: Olivier Sallin, i wsp.
Wydane: (2018-05-01)

Novel insight into nicotinamide adenine dinucleotide and related metabolites in cancer patients undergoing surgery
od: Hiroaki Fujita, i wsp.
Wydane: (2024-07-01)

Nicotinamide Riboside Regulates Chemotaxis to Decrease Inflammation and Ameliorate Functional Recovery Following Spinal Cord Injury in Mice
od: Yan Li, i wsp.
Wydane: (2024-02-01)

Nicotinamide riboside alleviates exercise intolerance in ANT1-deficient mice
od: Patrick M. Schaefer, i wsp.
Wydane: (2022-10-01)

Nicotinamide Riboside and Phycocyanin Oligopeptides Affect Stress Susceptibility in Chronic Corticosterone-Exposed Rats
od: Cemal Orhan, i wsp.
Wydane: (2023-10-01)

Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men
od: Shintaro Yamaguchi, i wsp.
Wydane: (2024-02-01)

Nicotinamide riboside supplementation ameliorates ovarian dysfunction in a PCOS mouse model
od: Zhenye Zhu, i wsp.
Wydane: (2025-01-01)

Progress in research on mechanism of nicotinamide adenine dinucleotide and its precursors against aging-related diseases
od: Shixiong ZHENG, i wsp.
Wydane: (2023-06-01)

Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer
od: Lola E. Navas, i wsp.
Wydane: (2022-08-01)

Extension of use of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283
od: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), i wsp.
Wydane: (2021-11-01)

Erythrocyte nicotinamide adenine dinucleotide concentration is enhanced by systematic sports participation
od: Barbara Pospieszna, i wsp.
Wydane: (2024-10-01)

Navigating Alzheimer’s Disease Mouse Models: Age-Related Pathology and Cognitive Deficits
od: Laura Maria De Plano, i wsp.
Wydane: (2024-11-01)

Effects of Nicotinamide Riboside Supplementation on Postmortem Mitochondrial Functionality and Apoptotic Activation
od: Chen Zhu, i wsp.
Wydane: (2025-01-01)

Axonal Protection by Oral Nicotinamide Riboside Treatment with Upregulated AMPK Phosphorylation in a Rat Glaucomatous Degeneration Model
od: Ibuki Arizono, i wsp.
Wydane: (2023-08-01)

Gastrodin as a multi-target protective compound reverses learning memory deficits and AD-like pathology in APP/PS1 transgenic mice
od: Yue-Qin Zeng, i wsp.
Wydane: (2021-02-01)

Rational Design for Improving the Thermostability of Saccharomyces cerevisiae Nicotinamide Riboside Kinase 1
od: WANG Yao, SHEN Taisong, LI Sichen, SHI Hongling, YAO Lunguang, TANG Cunduo
Wydane: (2024-12-01)

Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
od: Nahid A Khan, i wsp.
Wydane: (2014-04-01)

The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential
od: Xiaokai Zhang, i wsp.
Wydane: (2022-07-01)

S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
od: Angela Lee, i wsp.
Wydane: (2023-11-01)

Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
od: Elizabeth A. Novak, i wsp.
Wydane: (2023-09-01)

The Role of NAD<sup>+</sup> in Metabolic Regulation of Adipose Tissue: Implications for Obesity-Induced Insulin Resistance
od: Tatjana Ruskovska, i wsp.
Wydane: (2023-09-01)

Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic stroke
od: Jiamei Shen, i wsp.
Wydane: (2019-01-01)

Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR)
od: Juan Carlos Rivera, i wsp.
Wydane: (2024-05-01)

Nicotinamide adenine dinucleotide treatment confers resistance to neonatal ischemia and hypoxia: effects on neurobehavioral phenotypes
od: Xiaowen Xu, i wsp.
Wydane: (2024-01-01)

Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease
od: Giorgio Turconi, i wsp.
Wydane: (2024-07-01)

Pathways Linking Nicotinamide Adenine Dinucleotide Phosphate Production to Endoplasmic Reticulum Protein Oxidation and Stress
od: Erica R. Gansemer, i wsp.
Wydane: (2022-05-01)

Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis
od: Ou Zhong, i wsp.
Wydane: (2022-03-01)